These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 24696260)
1. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer. Pryczynicz A; Guzińska-Ustymowicz K; Niewiarowska K; Cepowicz D; Kemona A Tumour Biol; 2014 Jul; 35(7):6587-92. PubMed ID: 24696260 [TBL] [Abstract][Full Text] [Related]
2. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563 [TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511 [TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324 [TBL] [Abstract][Full Text] [Related]
6. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. Dai N; Lu AP; Shou CC; Li JY World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925 [TBL] [Abstract][Full Text] [Related]
7. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
8. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma. Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843 [TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia. Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555 [TBL] [Abstract][Full Text] [Related]
10. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206 [TBL] [Abstract][Full Text] [Related]
11. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis. Hu L; Luo H; Wang W; Li H; He T PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707 [TBL] [Abstract][Full Text] [Related]
14. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. Zhang C; Tian W; Meng L; Qu L; Shou C J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949 [TBL] [Abstract][Full Text] [Related]
15. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710 [TBL] [Abstract][Full Text] [Related]
17. Phosphatase of regenerating liver-3 as a prognostic biomarker in histologically node-negative gastric cancer. Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M Oncol Rep; 2009 Jun; 21(6):1467-75. PubMed ID: 19424625 [TBL] [Abstract][Full Text] [Related]
18. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Miskad UA; Semba S; Kato H; Yokozaki H Pathobiology; 2004; 71(4):176-84. PubMed ID: 15263806 [TBL] [Abstract][Full Text] [Related]
19. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Gao H; Lan X; Li S; Xue Y Tumour Biol; 2017 May; 39(5):1010428317698368. PubMed ID: 28459196 [TBL] [Abstract][Full Text] [Related]
20. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Cai J; Ikeguchi M; Tsujitani S; Maeta M; Liu J; Kaibara N Gastric Cancer; 2001; 4(2):66-74. PubMed ID: 11706763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]